Skip navigation
  • Home
  • Browse
    • Communities
      & Collections
    • Browse Items by:
    • Publication Date
    • Author
    • Title
    • Subject
    • Department
  • Sign on to:
    • My MacSphere
    • Receive email
      updates
    • Edit Profile


McMaster University Home Page
  1. MacSphere
  2. Open Access Dissertations and Theses Community
  3. Digitized Open Access Dissertations and Theses
Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/23233
Title: O-Glycosylation of B-Catenin Regulates its Nuclear Localization and Transcriptional Activity
Authors: Sayat, Ria
Advisor: Persad, S.
Department: Biochemistry and Biomedical Sciences
Keywords: glycosylation;beta-catenin;nuclear;transcription
Publication Date: Feb-2007
Abstract: B-catenin is a transcriptional co-activator in the Wnt signaling pathway. Upon Wnt stimulation, cytosolic B-catenin translocates into the nucleus where it forms complexes with members of the TCF /LEF family of transcription factors to activate gene transcription. Translocation into the nucleus is followed by transcriptional activation of B-catenin's target genes, which are involved in proliferation, angiogenesis and oncogenesis, is a crucial step in the progression of a subset of cancers. The cellular expression of B-catenin is known to be regulated by phosphorylation. However, the mechanisms(s) responsible for B-catenin nuclear entry is not well understood. Recently, B-catenin was reported to be post-translationally modified by O-glycosylation in breast cancer cells. We investigated whether O-glycosylation regulates the signal transduction properties of the protein. Our results indicated that while there are higher levels of total B-catenin in the nucleus of two prostate cancer cell lines (DU-145 and LNCaP) compared to that in a normal prostate epithelial cell line (PNT1A), most of it was in the unglycosylated form. Also, the normal prostate cell line exhibited higher levels of O-glycosylated B-catenin in both the nucleus and cytosol than what was seen in the two prostate cancer cell lines. We carried out further experiments using PUGNAc, a non-cytotoxic reversible inhibitor of O-GlcNAcase, which causes a time dependent increase in cellular levels of O-glycosylated B-catenin. Treatment of prostate cancer cells with PUGNAc caused a decrease in the expression of B-catenin in the nucleus with increasing cellular O-glycosylation of the protein suggesting that O-glycosylation was hindering B-catenin nuclear translocation. Additional studies showed that O-glycosylation of B-catenin decreased that transcriptional activity of a TopFlash reporter plasmid and the protein expression of two B-catenin target genes. Our results suggest that O-glycosylation of B-catenin may represent a novel mechanism important in the regulation of the nuclear localization and transcriptional activity of B-catenin.
URI: http://hdl.handle.net/11375/23233
Appears in Collections:Digitized Open Access Dissertations and Theses

Files in This Item:
File Description SizeFormat 
sayat_ria_2007Feb_masters.pdf
Open Access
13.65 MBAdobe PDFView/Open
Show full item record Statistics


Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.

Sherman Centre for Digital Scholarship     McMaster University Libraries
©2022 McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy | Feedback

Report Accessibility Issue